The Nasdaq-listed biopharma company and Willow Biosciences Inc. will work together to create new sustainable manufacturing routes for essential intermediates and active pharmaceutical ingredients (APIs). Willow Biosciences Inc. is a leading...
Pharmaceutical pellets are designed to release the medication slowly over a period of time, allowing for a more controlled and sustained release of the drug into the body. This method of delivery is particularly beneficial for medications that req...
Manufacturing of Active Pharmaceutical Ingredients (APIs) is a critical step in the productionof pharmaceutical drugs.
Contract manufacturing can assist Ayurvedic and Herbal Brands expand their product lines rapidly and in an efficient manner.
In a $3.5 billion transaction, Novartis will acquire US-based Chinook Therapeutics, a clinical-stage biopharmaceutical business. Upon reaching specific regulatory milestones, Chinook common investors will earn $3.2 billion and $0.3 billion in cash...
A current Active Pharmaceutical Ingredient (API) production plant in Denmark will be expanded as part of Novo Nordisk's announced plans to invest 15.9 billion Danish kroner beginning in 2023 for the company's future portfolio of major chronic...
The diagnostics industry is increasingly being shaped by innovative business models such as franchising, subscription-based services, and digital platforms.
Patient advocacy is a vital part of any successful pharmaceutical marketing strategy.
To commercialise distinctive and ground-breaking products in the areas of Maternal Health & Urology, CORONA Remedies Private Limited (CORONA) has entered into an agreement with Ferring Pharmaceuticals Pvt. Ltd. (Ferring), a subsidiary of global...
Cancer has long been a major health concern for people around the world. According to the World Health Organization (WHO), cancer is the second leading cause of death globally, accounting for nearly 10 million deaths in 2020 alone.
, CDSCO.jpg)
